Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Intracameral Zimoxin (0.1% Moxifloxacin Solution) for Prevention of Endophthalmitis After Cataract Surgery

NCT03244072 is registered in ClinicalTrials.gov with Jason Ahee, M.D. as lead sponsor.

NCT NCT03244072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03244072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Intracameral Zimoxin (0.1% Moxifloxacin Solution) for Prevention of Endophthalmitis After Cataract Surgery
Lead sponsor
Jason Ahee, M.D.
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
June 1, 2027
Completion date
October 31, 2031
Enrollment
60,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endophthalmitis